Our Impact 

Over the next six years, we plan to:

  1. Save 1.8 million children’s lives

  2. Treat 22.5 million children and 82 million pregnant women with RUTF and MMS, respectively

  3. Prevent more than 4.8 million cases of maternal anemia and 1.6 million low birthweight babies

We aim to achieve this by:

  1. Mobilizing $4 billion—with $1bn coming from the private sector and $3bn coming from public funds

  2. Driving a 20% overall reduction in cost for both treatments

  3. Delivering 3.2 billion packages of RUTF and 14 billion tablets of MMS

While RUTF and MMS are already among the most cost-effective ways to save lives, OES will make these solutions even more cost-effective.

Maximizing Impact

  • Cost Efficiency: By prioritizing cost-effectiveness and requiring competition and transparency at every stage of production, transportation, and programming, we can dramatically reduces overhead.

  • Strategic Scaling: Through long-term financing and a multi-year operational horizon, the organization secures more favorable contracts with producers and shippers while building resilient "last-mile" delivery systems.

  • Proven Innovation: By scaling successful innovations across procurement and programming, the organization significantly lowers overall costs and maximizes the reach of every dollar.

Examples of Proven innovative approaches that we will scale 

Longer-term agreements with manufacturers will help us negotiate cheaper contracts.

Lighter-weight cardboard boxes for RUTF reduce packaging and shipping costs.

Pre-positioning supplies in high-risk regions will help us lower transportation costs and reach kids in need more quickly.

Using the lowest effective dosage for RUTF will allow us to reach many more children. 

Working with Community Health Workers already operating in a community to deliver treatment will help us reach patients reliably and cost-effectively.